OM
Outset Medical, Inc.
$4.49
+4.42%
$83.2M
No data for this timeframe.
Vol
Market Cap$83.2M
Cap SizeMicro Cap
Inst. Holders43 funds
Inst. Value$33.7M
Inst. Activity6 buys / 3 sells
Insider Activity0B / 4S
Insider Net $-$115.7K
Reddit Sentiment50° Neutral
SEC Reports5
Press Releases1
Exchange Nasdaq·Sector Electromedical & Electrotherapeutic Apparatus·Inc. DE·CIK 0001484612·Prev Close $4.30
Recent Activity
Jun 11, 2026
SEC
In Q3 2025, three mega-passive institutional holders — BlackRock, State Street, and Morgan Stanley — collectively added
INST-CLUSTER — Impact 3/10
Jun 4, 2026
Insider
HACKETT PATRICK T was granted 10,667 shares
Director
Jun 4, 2026
Insider
OBOYLE KEVIN C was granted 10,667 shares
Director
Jun 4, 2026
Insider
Prange Karen was granted 10,667 shares
Director
May 21, 2026
other
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
<p align="justify">SAN JOSE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq
May 20, 2026
SEC
Three senior executives (CEO, EVP Operations, General Counsel) sold a total of ~$28K in OM stock on May 15, one week aft
CLUSTER — Impact 3/10
May 16, 2026
SEC
CEO Leslie Trigg filed a Form 144 to sell 3,445 shares of Outset Medical common stock, with an estimated aggregate marke
144 — Impact 2/10
Inst.
Woodline Partners LP — NEAR_EXIT
292,437 shares ($1.1M)
Price Targets
Historical data — last covering-analyst action Feb 2026. No current recommendation available.
$8.33 (Feb 2026)
Current $4.49
Low $7.00
Median $8.00
High $10.00
3 analysts
$7.00
$10.00
Analyst Ratings
4Strong Buy
5Buy
3Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Feb 12, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Jan 7, 2026 | Stifel | MAINTAIN | Buy → Buy |
| Dec 16, 2025 | BTIG | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.72 ▲ +2.2% | $-0.79 — $-0.63 | 15% YoY | 3 |
| Next Q | $-0.62 ▲ +2.1% | $-0.67 — $-0.54 | 11% YoY | 3 |
| Current FY | $-2.89 ▼ -2.1% | $-2.92 — $-2.85 | 33% YoY | 3 |
| Next FY | $-2.18 ▲ +7.0% | $-2.37 — $-2.02 | 25% YoY | 3 |
Latest Reports
NEUTRAL
INST-CLUSTER
3/10
In Q3 2025, three mega-passive institutional holders — BlackRock, State Street, and Morgan Stanley — collectively added
Jun 11, 2026
NEUTRAL
CLUSTER
3/10
Three senior executives (CEO, EVP Operations, General Counsel) sold a total of ~$28K in OM stock on May 15, one week aft
May 20, 2026
NEUTRAL
Press
3/10
Outset Medical announced equity awards to two new hires, including 96,000 RSUs to newly appointed Executive Vice Preside
Apr 8, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| ROYAL BANK OF CANADA | — | DOUBLED |
| FMR LLC | $10.5M | NEW |
| BlackRock, Inc. | $4.9M | ADD |
| BANK OF AMERICA CORP | $3.6M | DOUBLED |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.9M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 4, 2026 | HACKETT PATRICK | A | $0.00 |
| Jun 4, 2026 | OBOYLE KEVIN | A | $0.00 |
| Jun 4, 2026 | Prange Karen | A | $0.00 |
| Jun 4, 2026 | LANG BRENT | A | $0.00 |
| Jun 4, 2026 | GROSSMAN D | A | $0.00 |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
43 institutional holders with $33.7M total value (8,773,321 shares) as of 2026-Q1. Top holders: ROYAL, FMR, BlackRock,. Net buying activity: 6 institutions added/increased vs 3 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | ROYAL BANK OF CANADA | 89 | $0.00 | 0.0% | DOUBLED +2352.4% |
| 2 | FMR LLC | 2,741,673 | $10.5M | 31.2% | NEW |
| 3 | BlackRock, Inc. | 1,263,219 | $4.9M | 14.4% | ADD +26.9% |
| 4 | BANK OF AMERICA CORP /DE/ | 949,397 | $3.6M | 10.8% | DOUBLED +4023.7% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 763,822 | $2.9M | 8.7% | — |
| 6 | Assenagon Asset Management S.A. | 504,093 | $1.9M | 5.7% | ADD +34.8% |
| 7 | STATE STREET CORP | 334,994 | $1.3M | 3.8% | ADD +61.6% |
| 8 | Woodline Partners LP | 292,437 | $1.1M | 3.3% | NEAR_EXIT -77.9% |
| 9 | CITADEL ADVISORS LLC | 265,700 | $1.0M | 3.0% | DOUBLED +372.8% |
| 10 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 260,100 | $998.8K | 3.0% | — |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 222,075 | $852.8K | 2.5% | DOUBLED +391.3% |
| 12 | MORGAN STANLEY | 169,443 | $650.7K | 1.9% | TRIM -67.7% |
| 13 | DIMENSIONAL FUND ADVISORS LP | 113,365 | $435.0K | 1.3% | TRIM -28.4% |
| 14 | VANGUARD FIDUCIARY TRUST CO | 111,639 | $428.7K | 1.3% | — |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC | 98,610 | $378.7K | 1.1% | — |
| 16 | GOLDMAN SACHS GROUP INC | 93,360 | $358.5K | 1.1% | — |
| 17 | CITADEL ADVISORS LLC | 87,500 | $336.0K | 1.0% | DOUBLED +372.8% |
| 18 | BANK OF MONTREAL /CAN/ | 18,012 | $265.0K | 0.8% | — |
| 19 | Nuveen, LLC | 65,585 | $251.8K | 0.7% | ADD +88.3% |
| 20 | Centiva Capital, LP | 50,719 | $194.8K | 0.6% | DOUBLED +151.3% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Woodline Partners LP | NEAR_EXIT | 1,325,855 | 292,437 | -77.9% | $1.1M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 45,205 | 222,075 | +391.3% | $852.8K | 2026-Q1 |
| DIMENSIONAL FUND ADVISORS LP | TRIM | 158,352 | 113,365 | -28.4% | $435.0K | 2026-Q1 |
| Centiva Capital, LP | DOUBLED | 20,181 | 50,719 | +151.3% | $194.8K | 2026-Q1 |
| DEUTSCHE BANK AG\ | NEAR_EXIT | 177,681 | 30,383 | -82.9% | $116.7K | 2026-Q1 |
| CWM, LLC | DOUBLED | 3,680 | 22,139 | +501.6% | $85.0K | 2026-Q1 |
| Russell Investments Group, Ltd. | DOUBLED | 1,468 | 4,074 | +177.5% | $15.6K | 2026-Q1 |
| Allworth Financial LP | DOUBLED | 8 | 600 | +7400.0% | $2.3K | 2026-Q1 |
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | 28,627 | 39,427 | +37.7% | $152.00 | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 23,051 | 950,544 | +4023.7% | $3.5M | 2025-Q4 |
| Assenagon Asset Management S.A. | ADD | 377,033 | 508,414 | +34.8% | $1.9M | 2025-Q4 |
| MARSHALL WACE, LLP | TRIM | 419,118 | 170,758 | -59.3% | $633.5K | 2025-Q4 |
| DIMENSIONAL FUND ADVISORS LP | DOUBLED | 33,535 | 158,352 | +372.2% | $587.4K | 2025-Q4 |
| MORGAN STANLEY | TRIM | 433,175 | 139,719 | -67.7% | $518.4K | 2025-Q4 |
| Nuveen, LLC | ADD | 34,676 | 65,304 | +88.3% | $242.3K | 2025-Q4 |
| NATIONAL BANK OF CANADA /FI/ | ADD | 34,662 | 45,723 | +31.9% | $170.1K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 11,639 | 18,271 | +57.0% | $67.8K | 2025-Q4 |
| Russell Investments Group, Ltd. | NEAR_EXIT | 12,391 | 1,468 | -88.2% | $5.4K | 2025-Q4 |
| FEDERATED HERMES, INC. | NEAR_EXIT | 72,117 | 709 | -99.0% | $2.6K | 2025-Q4 |
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | 14,827 | 28,627 | +93.1% | $107.00 | 2025-Q4 |
| Allworth Financial LP | TRIM | 12 | 8 | -33.3% | $30.00 | 2025-Q4 |
| CWM, LLC | DOUBLED | 1,584 | 3,680 | +132.3% | $14.00 | 2025-Q4 |
| Durable Capital Partners LP | EXIT | 1,023,706 | 0 | -100.0% | $0.00 | 2025-Q4 |
| BlackRock, Inc. | ADD | 983,891 | 1,248,956 | +26.9% | $17.6M | 2025-Q3 |
| Durable Capital Partners LP | TRIM | 1,657,126 | 1,023,706 | -38.2% | $14.5M | 2025-Q3 |
12 unique insiders with 14 transactions. Net insider value: -$115.7K ($0.00 bought, $115.7K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | HACKETT PATRICK T | Director | AWARD | 10,667 | — | — |
| Jun 4, 2026 | OBOYLE KEVIN C | Director | AWARD | 10,667 | — | — |
| Jun 4, 2026 | Prange Karen | Director | AWARD | 10,667 | — | — |
| Jun 4, 2026 | LANG BRENT D. | Director | AWARD | 10,667 | — | — |
| Jun 4, 2026 | GROSSMAN D KEITH | Director | AWARD | 10,667 | — | — |
| Jun 4, 2026 | Drexler Karen | Director | AWARD | 10,667 | — | — |
| Jun 3, 2026 | Gaeta Renee | Chief Financial Officer | SELL | 17,672 | $4.94 | $87.3K |
| May 15, 2026 | Leonard Braden Michael | 10%+ Owner | EXERCISE | 323,000 | $5.00 | $1.6M |
| May 15, 2026 | Brottem John L. | General Counsel | SELL | 2,638 | $3.70 | $9.8K |
| May 15, 2026 | Nash Marc | EVP Operations R&D & Service | SELL | 1,582 | $3.70 | $5.9K |
| May 15, 2026 | Trigg Leslie | Chair and CEO | SELL | 3,445 | $3.70 | $12.7K |
| May 11, 2026 | Leonard Braden Michael | 10%+ Owner | EXERCISE | 96,900 | $5.00 | $484.5K |
| May 8, 2026 | Leonard Braden Michael | 10%+ Owner | EXERCISE | 197,600 | $5.00 | $988.0K |
| Apr 6, 2026 | Elliott Derick A. | EVP, Commercial | AWARD | 96,000 | — | — |
5 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 5 neutral. Avg impact: 2.4/10.
NEUTRAL
INST-CLUSTER
3/10
In Q3 2025, three mega-passive institutional holders — BlackRock, State Street, and Morgan Stanley —
Jun 11, 2026
NEUTRAL
CLUSTER
3/10
Three senior executives (CEO, EVP Operations, General Counsel) sold a total of ~$28K in OM stock on
May 20, 2026
NEUTRAL
144
2/10
CEO Leslie Trigg filed a Form 144 to sell 3,445 shares of Outset Medical common stock, with an estim
May 16, 2026
NEUTRAL
PRESS-RELEASE
2/10
Outset Medical announced it will release Q1 2026 financial results on May 7, 2026, after market clos
Apr 27, 2026
NEUTRAL
DEFA14A
2/10
Outset Medical is holding its 2026 annual meeting with three key proposals: electing directors Brent
Apr 24, 2026
Historical analyst distribution (last covering-analyst action Feb 2026): 75% buy across 12 analysts — 4 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Feb 2026. No current recommendation available.
$8.33 mean target (Feb 2026)
$7.00 Low
$10.00 High
| Metric | Value |
|---|---|
| Current Price | $4.49 |
| Target Low | $7.00 |
| Target Mean | $8.33 |
| Target Median | $8.00 |
| Target High | $10.00 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.72 | $-0.79 | $-0.63 | 14.7% | +2.2% | 2↑ 0↓ | $0.0B | -5.1% | 3 |
| Next Q 2026-09-30 |
$-0.62 | $-0.67 | $-0.54 | 10.6% | +2.1% | 1↑ 1↓ | $0.0B | 15.5% | 3 |
| Current FY 2026-12-31 |
$-2.89 | $-2.92 | $-2.85 | 32.7% | -2.1% | 1↑ 2↓ | $0.1B | 6.0% | 3 |
| Next FY 2027-12-31 |
$-2.18 | $-2.37 | $-2.02 | 24.6% | +7.0% | 1↑ 2↓ | $0.1B | 10.9% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.717 | |
| 7d ago | $-0.747 | +0.030 |
| 30d ago | $-0.733 | +0.016 |
| 60d ago | $-0.733 | +0.016 |
| 90d ago | $-0.780 | +0.063 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Feb 12, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jan 7, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Dec 16, 2025 | BTIG | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 5 | 3 | 0 | 0 | 75% | |
| May 1, 2026 | 4 | 5 | 3 | 0 | 0 | 75% | |
| Apr 1, 2026 | 5 | 5 | 3 | 0 | 0 | 77% | |
| Mar 1, 2026 | 5 | 5 | 3 | 0 | 0 | 77% | |
| Feb 1, 2026 | 5 | 5 | 3 | 0 | 0 | 77% | |
| Jan 1, 2026 | 5 | 5 | 3 | 0 | 0 | 77% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
1 mentions
0 bullish
0 bearish
1 time period
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Mar 21, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
May 21, 2026
other
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
<p align="justify">SAN JOSE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a f
May 7, 2026
earnings
Outset Medical Reports First-Quarter Results
<p align="justify">SAN JOSE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a f
May 7, 2026
earnings_calendar
OM Q1 2026 Earnings Scheduled — 2026-05-07
May 5, 2026
earnings_calendar
OM Q1 2026 Earnings Scheduled — 2026-05-05
Apr 27, 2026
earnings
Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026
<p align="justify">SAN JOSE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company p
Apr 8, 2026
regulatory
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
<p align="justify">SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a
Apr 6, 2026
leadership
Outset Medical Names Derick Elliott as Executive Vice President of Commercial
<p align="justify">SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a